One stock that just can't seem to catch a break of late is Pfizer (NYSE: PFE). Given how well Pfizer has performed in recent years due to its COVID-19 vaccine and pill (its revenue topped $100 billion ...
The BMA continues to ensure that doctors’ experiences during the pandemic are heard and learnt from. We are actively contributing to the UK Covid Inquiry to ensure that crucial lessons are learned and ...